Sarah Ford | April 18, 2014
Researcher Examines Impact of Extra Chromosome on Acute Myeloid Leukemia
David Gordon, MD, PhD at Dana Farber Cancer Institute is a CureSearch Young Investigator examining the impact of trisomy 8 on acute myeloid leukemia (AML). Of the 500 children diagnosed with AML each year, between 10-20% of an extra chromosome 8, called trisomy 8.
Dr. Gordon suspects that trisomy 8 contributes to the creation of cancerous cells because certain genes are expressed when an abnormal number of chromosomes are present. Using three cell lines he previously developed, Dr. Gordon spent the first year of his CureSearch grant screening the cell lines for new AML target genes and investigating the impact of trisomy 8 in blood cell development.
In the coming year, Dr. Gordon will explore how these genes, and their interaction with trisomy 8, lead to the development of AML.
Get Resources and Insights Straight To Your Inbox
Explore More Articles
The Future of Corporate Giving: How Nonprofits Can Prepare
Corporate giving is a valuable part of the nonprofit funding ecosystem. Companies large and small have incorporated philanthropic efforts into their overall business plans, from…
Read Article
Join Us at the Workplace Fundraising & Volunteering Summit!
We’re excited to announce that America’s Charities President, Jim Starr, and Board Member, Fernando Lorence of JP Morgan Chase, will be speaking at the Workplace…
Read Article
Breast Cancer Awareness Month
October is Breast Cancer Awareness Month – an annual campaign that aims to educate the public on the importance of early screening, testing and treatment for…
Read ArticleGet Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
